Patients interested in these medications should consult healthcare providers to determine the best option based on their health profile and treatment goals
Additional Toppings - Top with fresh herbs such as parsley
Clinical data supports the idea that staying on a stable dose preserves weight loss benefits indefinitely
The Kidney Disease Improving Global Outcomes 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends adults with CKD and either an eGFR 20 mL/min/1.73 m 2 or higher plus UACR of 200 mg/g or higher, or those with heart failure, receive SGLT2 inhibitor therapy
Medication Adherence While medication adherence factors into outcomes associated with most all drugs, it is especially important with GLP1 receptor agonists, as significant weight gain frequently occurs after discontinuation of the drug
These effects often ease over time, particularly with gradual dose increases and supportive measures like eating smaller meals and staying hydrated